Cidofovir
      J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AB - Nucleosides And Nucleotides Excl. Reverse Transcriptase Inhibitors -> J05AB12 - Cidofovir
    
          
        Administration category:
         Limited
      
    
          
        Medicine group:
        antiviral
      
    
    
      Standard dosages
| Weight | ROA | Load | Dosage | |
|---|---|---|---|---|
| ROA: po | Load: - | Dosage: | ||
| Comments: 5mg/kg cidofovir 1x per week gedurende 2 weken, vervolgens 5mg/kg 1x elke 2 weken | ||||
Kidney function
| ROA | GFR | Dosage | Interval | Comments | 
|---|---|---|---|---|
| ROA: | ||||
Notes GFR general:
Nefroprotectieve maatregelen: voor elke cidovofir-infusie prehydreren met 1½L NaCl 0.9% in 1½h, daarna nog eens 500 ml NaCl 0.9% gelijktijdig met de cidofovir-infusie in laten inlopen.
Voor en na elke cidovofir toediening tevens probenecid voorschrijven: 2 gram per os 3 uur voor en 1 gram per os 2 uur en 8 uur (in totaal 4 gram) na cidofovir toediening.
            
              
                Dosage: 
                dependent on kidney function
              
            
                    
        Renal function-replacement therapy
CAPD: 0,5 mg/kg/dosis, zonder probenecid
Hemo dialysis: Standaard inductie of onderhoudsdosis; 2 uur vóór hemodialyse, zonder probenecid
CAV / VVHD: 1x per week 3-4 mg/kg gedurende 2 weken Vervolgens: 1x per twee weken 3-4 mg/kg
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
          
            For individual advice, consult an expert on site.          
        
      Metadata
            Swab vid: M-501429.2
            Updated: 07/30/2024 - 13:40
            Status: Published
          
 
          
General comments
Brody SR, Humphreys MH, Gambertoglio JG, Schoenfeld P, Cundy KC, Aweeka FT. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Clin Pharmacol Ther. 1999;65(1):21-28. doi:10.1016/S0009-9236(99)70118-9
Vossen MG, Gattringer KB, Jager W, et al: Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration. Antimicrob Agents Chemother 2014; 58(4):1952-1955